LifeStance HealthLFST.OValuation Analysis
Based on the blended 10-year P/E and P/B percentiles, the stock currently sits in the “Fair Value Range” zone.
As of Oct 16, 2026, LifeStance Health (LFST.O) trades at a P/E of 89.00x, P/B of 3.04x, P/S of 2.83x, and a dividend yield of 0.00%.
Longitudinal percentile comparison: P/E sits at the 21st percentile over the trailing 10Y window (vs. 21st percentile over 3Y); P/B sits at the 90th percentile over the trailing 10Y window (vs. 94th percentile over 3Y); P/S sits at the 62nd percentile over the trailing 10Y window (vs. 93rd percentile over 3Y).
Cross-sectional valuation: its P/E ranks at the 88th percentile within its industry and the 92nd percentile across the broader market.
Shareholder return highlight: Total Shareholder Yield is 0.00%; its historical percentile over the trailing long-term window is still accumulating data.
The P/E and P/B percentiles diverge here, differing by 68.6 points — relying on either metric alone could be misleading. Its P/E percentile is roughly the same whether measured against the industry or the broader market. Shareholder returns here are driven almost entirely by cash dividends, with minimal contribution from buybacks. LifeStance Health operates in the Services sector. Data refreshes weekly and is for reference only, not investment advice.
Also listed as: NASDAQ: LFST · LFST
Want the full picture on whether LifeStance Health (LFST.O) is under- or over-valued? See the full 3Y / 5Y / 10Y / 20Y P/E, P/B, P/S, Dividend Yield & Total Shareholder Yield percentile matrix and the interactive ECharts trend chart on this page.
Historical Percentiles by Metric
| Metric | Current | Market Percentile | Industry Percentile | 3Y Pctl | 5Y Pctl | 10Y Pctl | 20Y Pctl |
|---|---|---|---|---|---|---|---|
| P/E (TTM) | 89.00 | ||||||
| P/B (MRQ) | 3.04 | ||||||
| P/S (TTM) | 2.83 | ||||||
| Dividend Yield | 0.00% | 0 | 0 | 0 | 0 | 0 | 0 |
| Buyback + Div Yield | 0.00% | 0 | 0 | 0 | 0 | 0 | 0 |